Review Article

Future Perspectives: Therapeutic Targeting of Notch Signalling May Become a Strategy in Patients Receiving Stem Cell Transplantation for Hematologic Malignancies

Table 1

Notch ligand-receptor interaction: a summary of possible interactions involved in normal hematopoiesis, T cell development, and regulation of the peripheral T cell system.

SIGNAL-INITIATING CELLSIGNAL-RECEIVING CELL
Cell typeLigandCell typeReceptorReferences

Bone marrow stromal cellsBone marrow stem cells
 Osteoblasts (endosteal niche)JAG1Sca-1+, c-kit+, Lin-Notch1 [13]
JAG1, JAG2Sca-1+, c-kit+, CD117+Notch1, Notch2 [52]
 Endothelial cells (vascular niche)JAG1, JAG2, DLL4, DLL1Sca-1+, c-kit+, Lin- Notch1, Notch2 [24]

Thymic epithelial cells (TECs)T cell progenitors
 TECsDLL4ThymocytesNotch1 [1, 50]

Antigen-presenting cellsPeripheral T cells
 APCDLL1TcNotch1, Notch2[1]
 DCDLL1, DLL4Th1Notch3 [1, 8, 53]
 DCJAG1, JAG2Th2Notch1, Notch2 [1, 8, 53]
 APCDLL1, DLL4Th17Notch [1, 54]
 pDCDLL4Th1 IL-10+Notch[55]

Abbreviations: Delta-like (DLL); Jagged (JAG); Thymic epithelial cells (TECs); Antigen presenting cells (APC); Dendritic cells (DC); plasmacytoid DC (pDC); Cytotoxic T cells (Tc); Helper T cells (Th); Interleukin-10 (IL-10).